4//SEC Filing
Gemphire Therapeutics Inc. 4
Accession 0001596771-17-000022
$MTVACIK 0001638287operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:57 PM ET
Size
7.1 KB
Accession
0001596771-17-000022
Insider Transaction Report
Form 4
LICHTINGER PEDRO
Director
Transactions
- Purchase
Common Stock
2017-03-10$9.47/sh+10,559$99,994→ 59,833 total - Purchase
Warrant to Purchase Common Stock
2017-03-10$9.47/sh+7,920$75,002→ 7,920 totalExercise: $10.40From: 2017-03-10Exp: 2022-03-15→ Common Stock (7,920 underlying)
Footnotes (1)
- [F1]The shares of common stock were purchased as part of a private placement pursuant to a Securities Purchase Agreement whereby the Issuer sold units consisting of one share of the Issuer's common stock and a warrant to purchase 0.75 shares of the Issuer's common stock at a per unit price of $9.47. The private placement is expected to close on March 15, 2017.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001638287
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:57 PM ET
- Size
- 7.1 KB